Navigation Links
ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
Date:6/17/2010

CONSHOHOCKEN, Pa., June 17 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical research technologies and niche clinical services, launches version 3.0 of its eMVR (Electronic Monitor Visit Report) application with new features to support online and offline completion of monitoring reports for traveling clinical research associates and integrations with leading CTMS systems.

"Our latest release provides study monitors with the option of completing monitor reports online or offline, more robust reporting, and CTMS integration points," stated Steven Beales, ePharmaSolutions' Vice President of Information Technology.

ePharmaSolutions' Clinical Trial Portal (CTP) is used by more than 200,000 clinical researchers in 107 countries to help accelerate and improve site feasibility, study training, site activation and patient enrollment.  CTP version 4.0 contains new functionality for sponsors that includes eMVR (Electronic Monitor Visit Report) to support the authoring, completion and submission of online and offline monitor trip reports with electronic signature.  The new version of eMVR allows study monitors to complete their site visit reports online or offline in Microsoft Word.  The offline reports can be submitted back to the eMVR and the data is pulled from the Word template back into the system.  The eMVR auto-populates visit reports, confirmation and follow-up letters, and carries all follow-up data from one report to either follow-up letters or future visit reports.  The eMVR includes a robust tracking and reporting system for study managers and integrates with leading CTMS systems.

"Our clients have been asking for an offline monitor visit report completion feature for some time and the market has not been responding in a timely enough manner," stated Lance Converse, ePharmaSolutions' Founder and CEO.  "Our development team did an excellent job building out these features into this release to support the global needs of our biopharmaceutical and CRO clients," Converse added.

ePharmaSolutions' Clinical Trial Portal (CTP) provides biopharmaceutical companies and CROs with a fully validated solution to help accelerate and improve study start-up and site management through a variety of "Site Friendly" components that include: site feasibility application (SFA), secure document exchange (SDE), safety letter distribution (SLD), electronic monitor visit reporting (eMVR), learning management system (LMS), and the patient recruitment manager (PRM).  Future plans in 2010 include the inclusion of a grant payment tracking application for sponsors/sites and integration of 80 million EMR records into its investigator database for improved decision support during the site selection process.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to start clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 185,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world and is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
2. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
3. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
4. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
5. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
6. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
7. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
8. Premier Micronutrient Launches Supplement for Hearing Health
9. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
(Date:12/7/2016)... PHILADELPHIA , Dec. 7, 2016  Lannett Company, Inc. (NYSE: ... at the BMO Capital Markets 2016 Prescription for Success Healthcare Conference ... Barclay hotel in New York City . ... investors participating at the Guggenheim Securities 4 th Annual Boston ... Boston hotel. ...
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a certified ... Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility ... patients realize their family building goals. Acupuncture helps fertility patients by ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief ... the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of ... can for this country. , Nancy attributes her patriotic nature to her WWII veteran ...
(Date:12/7/2016)... ... ... “Fred Rides a Train” allows readers to tag along on a special ... Train” is the creation of published author, Janet Morrison, who has been writing mostly ... "Fred, the Dog" series is her first attempt at writing for children. Janet, Fred, ...
Breaking Medicine News(10 mins):